Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber
Status:
Completed
Trial end date:
2007-01-16
Target enrollment:
Participant gender:
Summary
This study was designed to look at safety aspects and effects of intranasal doses of
GW784568X on allergic rhinitis symptoms to develop this drug for its use in people who suffer
with allergic rhinitis